Walton, M I <br/><br/>
Preclinical pharmacology and antitumour activity of the novel sequence-selective DNA minor-groove cross-linking agent DSB-120.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1996 
 - 431-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s002800050507  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemistry<br/>Benzodiazepinones--chemistry<br/>Cell Survival--drug effects<br/>Chromatography, High Pressure Liquid<br/>Cisplatin--pharmacology<br/>Colonic Neoplasms--drug therapy<br/>Doxorubicin--pharmacology<br/>Drug Stability<br/>Female<br/>Leukemia L1210--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Plasmacytoma--drug therapy<br/>Protein Binding<br/>Tumor Cells, Cultured--drug effects